Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming ...

Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated ...

Intermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge ...

CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

A boy who was told on his 16th birthday that the cancer he had been free from for 18 months had returned and spread to his ...

Despite the safety and simplicity, myths prevail in India—fuelled mostly by a lack of awareness and cultural resistance to ...

Liam Harrison plans to be as healthy as possible ahead of his highly anticipated ONE Championship return in September.

Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated regulatory pathway SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- ...

Cardiovascular disease and kidney disease are two of the most urgent issues in global public health. In the United States ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...

A patient with relapsed/refractory non-Hodgkin lymphoma received the first dose of a two-step radiotherapy using the ...